Nebilet Plus (Hydrochlorothiazide, Nebivolol)

Nebivolol blocks β1‑adrenergic receptors, decreasing heart rate and contractility while enhancing nitric‑oxide mediated vasodilation. Hydrochlorothiazide acts on the distal convoluted tubule to inhibit sodium‑chloride reabsorption, promoting diuresis and reducing plasma volume. Together they lower peripheral resistance and blood pressure.

The specific dose of Nebilet Plus is determined by the prescribing healthcare professional based on the individual’s blood pressure, medical history, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety of Nebilet Plus in pregnancy or while breastfeeding has not been fully established. Healthcare providers usually weigh the benefits against potential risks and may recommend alternative treatments if safer options are available.

To request Nebilet Plus, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Nebilet Plus combines a thiazide diuretic with a β1‑selective blocker, offering dual mechanisms that can be more effective than monotherapy for some patients. Compared with single‑agent ACE inhibitors or calcium‑channel blockers, the combination may provide better blood‑pressure control but requires monitoring for electrolyte changes and heart‑rate effects.

Nebilet Plus tablets should be stored at room temperature, below 25 °C, in the original blister or bottle, protected from moisture and direct sunlight. Keep the product out of reach of children and do not use after the expiration date.

Nebilet Plus is taken orally, usually once daily, with or without food, as directed by the prescriber. Swallow the tablet whole with a glass of water and do not crush or chew it unless instructed otherwise.

Serious risks include severe hypotension, marked electrolyte disturbances (especially low potassium or sodium), gout attacks, and rare allergic reactions such as angioedema. Patients should seek immediate medical attention if they experience fainting, rapid heartbeat, severe muscle cramps, or signs of an allergic response.

Nebilet Plus is contraindicated in patients with known hypersensitivity to either component, severe renal impairment, uncontrolled electrolyte abnormalities, or those taking certain interacting medications such as potent CYP2D6 inhibitors without medical supervision. A healthcare professional should evaluate suitability before initiating therapy.